Capital Analysts LLC’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Hold |
1,715
| – | – | ﹤0.01% | 647 |
|
|
2025
Q1 | $109K | Hold |
1,715
| – | – | ﹤0.01% | 625 |
|
|
2024
Q4 | $114K | Buy |
1,715
+615
| +56% | +$40.9K | ﹤0.01% | 585 |
|
|
2024
Q3 | $77K | Hold |
1,100
| – | – | ﹤0.01% | 637 |
|
|
2024
Q2 | $71K | Buy |
1,100
+1,024
| +1,347% | +$66.1K | ﹤0.01% | 640 |
|
|
2024
Q1 | $5K | Buy |
+76
| New | +$5K | ﹤0.01% | 989 |
|